longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

MRNA 2X Long ETF

MRNX

81.41010.25% ( +7.570 )
Closed: Sep 11, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsWikiWikiRatingsRatingsCompositionCompositionDividendsDividends
LongbridgeAI
  • Weekly Recap | Moderna -1.09%, tumour vaccine milestone

    Weekly Review·4 hours ago
    MRNA+5.38%MRNY+4.71%
  • Dow Jones Futures: $100 Oil, Surging Yields Pressure Stocks With Fed Rate Hike Seen. Apple Leads New Buys.

    Unusual Whales·14 hours ago
    AAPL+1.75%MRNA+5.38%
  • Healthcare Stocks To Keep An Eye On - September 11th

    Market Beat·16 hours ago
    UNH-2.37%BSX-0.28%
  • Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis

    TradingKey·17 hours ago
    MRNA+5.38%MRNY+4.71%
  • New FDA Drug Approvals - August 2026

    rttnews·18 hours ago
    TAK+0.83%MRNA+5.38%
  • Frequency Electronics, ACV Auctions, HP And Other Big Stocks Moving Higher On Friday

    benzinga_article·20 hours ago
    - U.S. stocks traded higher on Friday, with the Dow Jones index climbing approximately 400 points. - Frequency Electronics shares surged 30.7% following first-quarter financial results that exceeded analyst estimates. - ACV Auctions shares jumped 44.3% after Copart announced a definitive agreement to acquire the company for $10.50 per share in cash.
    ACVA+44.18%DELL+11.98%
  • Evercore ISI Sticks to Its Hold Rating for Moderna (MRNA)

    Tip Ranks·21 hours ago
    MRNA+5.38%MRNX+10.25%
  • Amundi Reduces Stock Holdings in Moderna, Inc. $MRNA

    Market Beat·1 day ago, 07:12 AM
    MRNA+5.38%BLK+1.62%
  • Healthcare Stocks To Watch Now - September 8th

    Market Beat·Sep 8 at 05:02 PM
    NVS-0.23%MRNA+5.38%
  • 8 Health Care Stocks Whale Activity In Today’s Session

    benzinga_article·Sep 7 at 05:35 PM
    UNH-2.37%MRNA+5.38%
  • The Second Act of Biotech

    Tip Ranks·Sep 7 at 11:08 AM
    - Pfizer and Moderna are heavily investing in new medical fields such as obesity treatments and personalized cancer vaccines following the post-COVID revenue decline. - Pfizer completed its acquisition of Metsera for approximately $7 billion to secure the ultra-long-acting GLP-1 receptor agonist berobenatide. - Pfizer is advancing an extensive obesity program that includes 10 Phase 3 trials and over 20 overall studies to improve treatment convenience and efficacy.
    PFE+0.25%MRNA+5.38%
  • Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It

    Market Beat·Sep 6 at 12:50 PM
    ABBV+0.83%PHVS+1.36%
  • Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks

    businessinsider·Sep 5 at 03:15 PM
    UNH-2.37%MRNA+5.38%
  • Weekly Recap | Moderna +5.48%, consensus target below spot

    Weekly Review·Sep 5 at 07:36 AM
    MRNA+5.38%MRNY+4.71%
  • Moderna declines 3% in regular trading after downgrade, dilution concerns

    US Stock Market Update·Sep 4 at 01:46 PM
    MRNA+5.38%